Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 723 |
|
|||||
| News | - | ||||||
| Day High | 2.85 | Low High |
|||||
| Day Low | 2.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lisata Therapeutics Inc | LSTA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.85 | 10:30:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.75 | 2.75 | 2.85 | 2.85 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7 | 723 | $ 2.77 | $ 2,002 | - | 1.95 - 4.5329 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:30:53 | 1 | $ 2.775 | USD |
Lisata Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 23.68M | 8.31M | - | 0 | -20.84M | -2.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lisata Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LSTA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.10 | 3.10 | 2.68 | 2.86 | 7,702 | -0.25 | -8.06% |
| 1 Month | 3.38 | 3.3999 | 2.68 | 3.07 | 11,435 | -0.53 | -15.68% |
| 3 Months | 2.67 | 3.40 | 2.42 | 3.09 | 13,618 | 0.18 | 6.74% |
| 6 Months | 2.16 | 3.40 | 2.00 | 2.77 | 15,219 | 0.69 | 31.94% |
| 1 Year | 3.34 | 4.5329 | 1.95 | 2.92 | 19,658 | -0.49 | -14.67% |
| 3 Years | 8.80 | 9.38 | 1.95 | 3.91 | 24,555 | -5.95 | -67.61% |
| 5 Years | 8.80 | 9.38 | 1.95 | 3.91 | 24,555 | -5.95 | -67.61% |
Lisata Therapeutics Description
| Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. |
